283 related articles for article (PubMed ID: 33713301)
1. Protective Effects of Novel Substituted Triazinoindole Inhibitors of Aldose Reductase and Epalrestat in Neuron-like PC12 Cells and BV2 Rodent Microglial Cells Exposed to Toxic Models of Oxidative Stress: Comparison with the Pyridoindole Antioxidant Stobadine.
Elmazoglu Z; Prnova MS; Stefek M; Ceylan AF; Aschner M; Rangel-López E; Santamaria A; Karasu C
Neurotox Res; 2021 Jun; 39(3):588-597. PubMed ID: 33713301
[TBL] [Abstract][Full Text] [Related]
2. Combatting Nitrosative Stress and Inflammation with Novel Substituted Triazinoindole Inhibitors of Aldose Reductase in PC12 Cells Exposed to 6-Hydroxydopamine Plus High Glucose.
Elmazoglu Z; Prnova MS; Santamaria A; Stefek M; Karasu C
Neurotox Res; 2021 Apr; 39(2):210-226. PubMed ID: 33146867
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).
Reddy TN; Ravinder M; Bagul P; Ravikanti K; Bagul C; Nanubolu JB; Srinivas K; Banerjee SK; Rao VJ
Eur J Med Chem; 2014 Jan; 71():53-66. PubMed ID: 24275248
[TBL] [Abstract][Full Text] [Related]
4. Cemtirestat, an aldose reductase inhibitor and antioxidant compound, induces ocular defense against oxidative and inflammatory stress in rat models for glycotoxicity.
Reihanifar T; Şahin M; Stefek M; Ceylan AF; Karasu Ç;
Cell Biochem Funct; 2023 Aug; 41(6):622-632. PubMed ID: 37272424
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effect of Epalrestat on Hydrogen Peroxide-Induced Neurodegeneration in SH-SY5Y Cellular Model.
Lingappa S; Shivakumar MS; Manivasagam T; Somasundaram ST; Seedevi P
J Microbiol Biotechnol; 2021 Jun; 31(6):867-874. PubMed ID: 33820886
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase mediates endothelial cell dysfunction induced by high uric acid concentrations.
Huang Z; Hong Q; Zhang X; Xiao W; Wang L; Cui S; Feng Z; Lv Y; Cai G; Chen X; Wu D
Cell Commun Signal; 2017 Jan; 15(1):3. PubMed ID: 28057038
[TBL] [Abstract][Full Text] [Related]
7. (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors.
Kucerova-Chlupacova M; Halakova D; Majekova M; Treml J; Stefek M; Soltesova Prnova M
Chem Biol Interact; 2020 Dec; 332():109286. PubMed ID: 33038328
[TBL] [Abstract][Full Text] [Related]
8. Antioxidants in treating pathologies involving oxidative damage: an update on medicinal chemistry and biological activity of stobadine and related pyridoindoles.
Juranek I; Horakova L; Rackova L; Stefek M
Curr Med Chem; 2010; 17(6):552-70. PubMed ID: 20015031
[TBL] [Abstract][Full Text] [Related]
9. A dual-acting aldose reductase inhibitor impedes oxidative and carbonyl stress in tissues of fructose- and streptozotocin-induced rats: comparison with antioxidant stobadine.
Kaya A; Ceylan AF; Kavutcu M; Santamaria A; Šoltésová Prnová M; Stefek M; Karasu Ç
Drug Chem Toxicol; 2023 Oct; ():1-11. PubMed ID: 37795621
[TBL] [Abstract][Full Text] [Related]
10. Ranirestat has a stronger inhibitory activity on aldose reductase and suppresses inflammatory reactions in high glucose-exposed endothelial cells.
Ishibashi Y; Matsui T; Matsumoto T; Kato H; Yamagishi S
Diab Vasc Dis Res; 2016 Jul; 13(4):312-5. PubMed ID: 27190083
[TBL] [Abstract][Full Text] [Related]
11. Gedunin, A Neem Limonoid in Combination with Epalrestat Inhibits Cancer Hallmarks by Attenuating Aldose Reductase-Driven Oncogenic Signaling in SCC131 Oral Cancer Cells.
Tanagala KKK; Baba AB; Kowshik J; Reddy GB; Nagini S
Anticancer Agents Med Chem; 2018; 18(14):2042-2052. PubMed ID: 30062975
[TBL] [Abstract][Full Text] [Related]
12. [Protective Effect of Epalrestat against Oxidative Stress-induced Cytotoxicity].
Tatsunami R; Murao Y; Sato K
Yakugaku Zasshi; 2020; 140(11):1381-1388. PubMed ID: 33132274
[TBL] [Abstract][Full Text] [Related]
13. Aldose reductase inhibitor Epalrestat alleviates high glucose-induced cardiomyocyte apoptosis via ROS.
Wang X; Yu F; Zheng WQ
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):294-303. PubMed ID: 31389594
[TBL] [Abstract][Full Text] [Related]
14. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
[TBL] [Abstract][Full Text] [Related]
15. Ischemic postconditioning during reperfusion attenuates oxidative stress and intestinal mucosal apoptosis induced by intestinal ischemia/reperfusion via aldose reductase.
Wen SH; Ling YH; Li Y; Li C; Liu JX; Li YS; Yao X; Xia ZQ; Liu KX
Surgery; 2013 Apr; 153(4):555-64. PubMed ID: 23218881
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of epalrestat mediated through oxidative stress markers, cytokines and TAU protein levels in diabetic rats.
Jaiswal S; Mishra S; Torgal SS; Shengule S
Life Sci; 2018 Aug; 207():364-371. PubMed ID: 29936149
[TBL] [Abstract][Full Text] [Related]
17. Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression.
Banala VT; Urandur S; Sharma S; Sharma M; Shukla RP; Marwaha D; Gautam S; Dwivedi M; Mishra PR
Biomater Sci; 2019 Jun; 7(7):2889-2906. PubMed ID: 31086900
[TBL] [Abstract][Full Text] [Related]
18. Epalrestat, an Aldose Reductase Inhibitor Prevents Glucose-Induced Toxicity in Human Retinal Pigment Epithelial Cells In Vitro.
Senthilkumari S; Sharmila R; Chidambaranathan G; Vanniarajan A
J Ocul Pharmacol Ther; 2017; 33(1):34-41. PubMed ID: 27835059
[TBL] [Abstract][Full Text] [Related]
19. Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications.
Kovacikova L; Prnova MS; Majekova M; Bohac A; Karasu C; Stefek M
Molecules; 2021 May; 26(10):. PubMed ID: 34066081
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetes.
Ohmura C; Watada H; Azuma K; Shimizu T; Kanazawa A; Ikeda F; Yoshihara T; Fujitani Y; Hirose T; Tanaka Y; Kawamori R
Endocr J; 2009; 56(1):149-56. PubMed ID: 18997444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]